EAM’s Response to Horizon Europe and Progress on the Northern Ireland Protocol 27th February 2023 The Academy’s President has expressed strong support for the continued association of the UK with Horizon Europe, emphasizing that this alignment represents the best possible outcome for advancing health research and innovation. The President also acknowledges the positive developments regarding the Northern Ireland Protocol, viewing these advancements as crucial for maintaining collaborative scientific efforts across Europe. Horizon Europe: A Crucial Framework for Health Research Horizon Europe is one of the most significant research and innovation programs globally, providing essential support for scientific collaboration, funding, and innovation. The Academy’s President underscores that the UK’s participation in Horizon Europe is vital for sustaining the country’s leadership in health research and for facilitating groundbreaking discoveries that benefit both the UK and global populations. By remaining a part of this robust framework, UK researchers can continue to engage with their European counterparts, ensuring that health research advances in a collaborative and inclusive environment. The President highlights that Horizon Europe’s comprehensive funding opportunities and collaborative networks are instrumental in driving forward critical research in areas such as public health, biomedical science, and healthcare innovation. The program’s focus on addressing global health challenges aligns closely with the Academy’s mission to improve health outcomes through scientific excellence and international cooperation. Positive Developments on the Northern Ireland Protocol In addition to the UK’s participation in Horizon Europe, the President acknowledges the recent progress on the Northern Ireland Protocol as a significant step forward. This development is seen as essential for ensuring the seamless flow of scientific collaboration and maintaining the integrity of research partnerships across the UK and Europe. The President stresses that stable and predictable arrangements regarding Northern Ireland are crucial for fostering an environment in which scientific research can thrive. The Academy’s President also points out that the resolution of issues related to the Northern Ireland Protocol will help to eliminate uncertainties that could otherwise disrupt scientific collaborations and hinder the UK’s ability to contribute to and benefit from European research initiatives. This stability is vital for ensuring that the UK remains an attractive destination for top-tier research talent and for securing the long-term success of the nation’s scientific endeavors. Commitment to Collaborative Research The Academy remains fully committed to supporting collaborative research efforts that transcend borders. The President calls for continued engagement with European partners to strengthen research networks and maximize the impact of joint scientific initiatives. The Academy will work closely with policymakers and research institutions to ensure that the UK’s association with Horizon Europe continues to be a driving force for health research and innovation. The President also emphasizes the importance of fostering a research environment that encourages diversity, inclusion, and the free exchange of ideas across borders. By maintaining strong ties with European research programs, the UK can continue to lead in addressing global health challenges and contributing to the advancement of medical science. Conclusion The Academy’s President views the UK’s ongoing association with Horizon Europe and the positive progress on the Northern Ireland Protocol as critical developments for the future of health research. By securing these key outcomes, the UK is well-positioned to maintain its leadership in scientific innovation and to continue fostering collaborative efforts that improve health outcomes worldwide.
